Protein purification: designing the route, and choosing a provider

Purification is a sequence of trades between yield and purity, and every additional step costs material. A route designed around the analytics you actually need is shorter, cheaper and more reproducible than one designed to make a gel look impressive. This page covers how a route is put together, what to specify when you outsource it, and the analytics that should accompany the delivered material.

the FDA cGMP rule that applies once material is destined for a drug product
Part 211
the ICH guideline on deriving and characterising cell substrates
Q5D
good laboratory practice for nonclinical studies, 21 CFR
Part 58

Figures in this panel are the rules a contract biologics service is bought and audited against, named from the regulations and guidelines themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a services index it has not measured.

Designing the route, and the protein purification systems that run it

  1. Capture first, and quickly. The first step should take the target out of the crude mixture fast, usually by affinity where a tag or a natural ligand allows it. Speed matters because proteases and oxidation are working the whole time, and a slow capture costs activity you cannot recover later.
  2. Intermediate purification removes the near neighbours. Ion exchange or hydrophobic interaction separates the target from contaminants that survived capture, and this is where most of the real purity is won. It is also where most of the yield is lost, so the conditions deserve real development rather than a default method.
  3. Polish only if the application needs it. Size exclusion removes aggregate and exchanges buffer and is the usual final step. It is also dilute and slow. If the application tolerates the aggregate level after the intermediate step, the polish is a step you are paying for twice, once in cost and once in yield.
  4. Endotoxin and nucleic acid removal. Material destined for cells or animals needs endotoxin and host nucleic acid addressed explicitly, usually with a dedicated step and a lot-specific test. Treating these as incidental is the most common reason purified protein fails downstream.
  5. Buffer and format on delivery. Specify the final buffer, the concentration, the volume and whether the material is frozen, lyophilised or shipped cold. A protein delivered in the provider's default buffer frequently needs an exchange you then perform badly.

In house or outsourced

Outsourcing makes sense when the equipment, the column chemistry or the scale is beyond what the lab holds, or when the work is a one-off and building the method internally is not worth it. It makes less sense for a protein the lab will purify repeatedly, because the method knowledge is the asset.

Where you do outsource, ask for the method to be written up in enough detail that you could run it. A provider that treats a standard purification route as proprietary is selling you a dependency.

The analytics that should come with the material

At minimum: a purity determination with the method and the trace, a concentration determination with the method, an aggregate measurement where it matters, an endotoxin result where the material touches cells, and an identity confirmation. Identity is the one most often skipped and is the cheapest insurance in the list.

Ask for the raw traces rather than a summary certificate. The shape of a chromatogram tells you things a percentage never will.

Protein purification kits, columns and the scale between them

A kit is a small prepacked format with its buffers, intended for a few hundred micrograms to a few milligrams, and it is the right choice for screening constructs and for anything done once. Its cost per milligram is high and its capacity is fixed.

Above that, a column on a system gives control of flow, gradient and fractionation, and a far better cost per milligram. The decision point is usually how often the purification will be repeated rather than how much protein is wanted on one occasion.

His tag protein purification, other fusion tags and the price of removing them

A large fusion partner improves solubility and gives a robust capture step, and it is large enough that it usually has to be removed. That means a protease site, the protease, a second capture to remove the cleaved partner and the protease, and a yield loss at each stage.

Plan the removal when the construct is designed: which protease, whether its site leaves a scar, and whether the cleaved product can be separated from the uncleaved one. Retrofitting a cleavage strategy is the commonest reason a purification stalls at the second step.

Endotoxin: reduce, and then prove it

Endotoxin from a bacterial host binds tightly to many proteins, and removal resins work by binding it preferentially. They reduce it and rarely eliminate it, and they can bind the product too, so recovery has to be measured rather than assumed.

The only way to know where you are is to measure, by the compendial method, with an interference screen for your product. Where the material is for cell work or for an animal, set a limit in advance and treat it as a release criterion rather than a hope.

Fab purification, and what protein crystallography demands

Preparing an antibody fragment means a controlled digestion followed by removing the constant fragment, the undigested antibody and the protease, which is a separation problem rather than a digestion one. Incomplete digestion is the usual outcome of an unoptimised protocol.

Crystallography is the most demanding purification target there is: high purity, a single conformational species, no aggregate, and a buffer with as little as possible in it. A preparation that is adequate for an assay is frequently useless for a crystal, and the extra polishing step is not optional.

Common questions

What is the usual order of purification steps?
Capture to get the target out of the crude material quickly, intermediate purification to remove close contaminants, then a polish to remove aggregate and exchange buffer. Not every protein needs all three.
How much protein will I lose?
Every step costs yield, and the loss depends on the target and the conditions rather than on a general rule. This is the argument for the shortest route that meets the specification the application actually needs.
Should I purify in house or outsource?
Outsource one-offs and work that needs equipment or scale you do not have. Keep in house anything you will repeat, because the method knowledge is worth more than the first batch.
What analytics should accompany purified protein?
Purity with the method and trace, concentration with the method, aggregate where relevant, identity confirmation, and an endotoxin result if the material goes near cells or animals.
Kit, column or magnetic beads for protein purification?
A kit for screening constructs and one-off preparations of a few milligrams; a column on a system where the purification repeats, because the cost per milligram and the control of the separation are both far better.
Can an endotoxin removal resin remove all the endotoxin?
It reduces it rather than eliminating it, and it can bind the product too. Measure by the compendial method with an interference screen and set a limit in advance as a release criterion.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/protein-purification/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices